Vivo Capital, LLC Iovance Biotherapeutics, Inc. Transaction History

Vivo Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$12.38 - $19.1 $4.38 Million - $6.76 Million	354,057 Added 117.63%	655,057 $10.9 Million
Q4 2021 Feb 11, 2022	BUY	$16.55 - $27.63 $4.98 Million - $8.32 Million	301,000 New	301,000 $5.75 Million
Q3 2019 Nov 13, 2019	SELL	$17.99 - $26.0 $28.8 Million - $41.6 Million	-1,600,000 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$7.51 - $11.93 $12 Million - $19.1 Million	1,600,000 New	1,600,000 $14.2 Million

313

237M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.21B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.